NASDAQ:CVAC
Delisted

Curevac N.v Stock Forecast

etoro logo Buy CVAC
*Your capital is at risk
$4.66
+0 (+0%)
At Close: Apr 02, 2026

CVAC Performance

FAQ

What is the symbol for Curevac N.V. Stock and on which exchange is it traded?
The symbol for Curevac N.V. is CVAC and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Curevac N.V. Stock?
Curevac N.V. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

How to buy Curevac N.V. Stock?
Curevac N.V. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Curevac N.V. Stock.

What's the current price of Curevac N.V. Stock?
As of the end of day on the Apr 02, 2026, the price of an Curevac N.V. (CVAC) share was $4.66.

What is the 52-week high and low for Curevac N.V. Stock?
The 52-week high for Curevac N.V. Stock is $5.72 and the 52-week low is $2.48.

What is the market capitalization of Curevac N.V. Stock?
As of the Apr 02, 2026, the market capitalization of Curevac N.V. is 1.049B.
Click to get the best stock tips daily for free!
ABOUT CUREVAC N.V.
Curevac N.V
CureVac N.V., a clinical-stage biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA). It is developing prophylactic vaccines, such as mRNA-based vaccine candidates CV2CoV, which is in Phase 1 clinical trial against SARS-CoV-2; CV7202, a prophylactic mRNA-based vaccine, which has completed Phase 1 clinical trial for rabies virus glycoprotein; and CVSQIV, which is in Phase 1 cli...
GOLDEN STAR
Ticker Change Signal Date
IDYA
$28.98
7.87% Jun 12
DHI
$146.71
3.93% Jun 10
PHM
$118.49
2.86% Jun 10
EAT
$140.46
13.06% Jun 05
TPR
$140.47
3.84% Jun 04

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE